期刊文献+

慢病毒载体介导shRNA干扰对乳腺癌MCF-7细胞RSK4基因表达的影响 被引量:4

Inhibition of RSK4 gene expression in the breast cancer cell line MCF-7 using lentiviral vector-mediated shRNA interference
下载PDF
导出
摘要 目的观察慢病毒干扰载体(RSK4-RNAi-LV)转染对低侵袭、低转移潜能的乳腺癌MCF-7细胞中核糖体S6蛋白激酶4(ribosomal protein S6 kinase 4,RSK4)基因表达的影响。方法设计合成特异性的RSK4 shRNA干扰体RSK4-RNAi-LV,稳定转染至乳腺癌MCF-7细胞中,应用实时荧光定量PCR法和Western blot法检测RSK4 mRNA及其蛋白的表达情况。结果稳定转染慢病毒干扰载体至乳腺癌细胞后,72h开始检测到GFP荧光表达,90h后GFP荧光表达明显增强,RSK4 mRNA及其蛋白的表达均被明显抑制,抑制率分别为98.2%和80.1%。结论稳定转染RSK4-RNAi-LV可有效抑制乳腺癌MCF-7细胞中RSK4 mRNA及其蛋白的表达。 Objective To design a lentiviral vector-based system for exploring the effects of silencing the ribosomal protein S6 kinase 4(RSK4) gene in the human breast cancer cell line MCF-7. Methods A lentiviral RNA interference vector targeting the RSKd gene was designed and stably transfected into MCF-7 cells.Expression of RSK4 mRNA and protein was analyzed by real-time PCR and Western blotting. Results Stable transfection led to 98.2% inhibition of RSK4 mRNA and 80.1% inhibition of RSK4 protein. Con- clusion Stable transfection of the breast cancer cell line MCF-7 using a lentiviral RNA interference vector can significantly inhibit expression of RSK4 mRNA and protein.
出处 《中国癌症防治杂志》 CAS 2013年第1期20-23,共4页 CHINESE JOURNAL OF ONCOLOGY PREVENTION AND TREATMENT
基金 国家自然科学基金资助项目(30960427) 广西自然科学基金资助项目(桂科自0991231)
关键词 乳腺肿瘤 核糖体S6蛋白激酶4 SHRNA干扰 慢病毒载体 Breast neoplasms RSK4 shRNA interference Lentiviral
  • 相关文献

参考文献11

  • 1Thakur A, Rahman KW, Wu J, et al.Aberrant expression of X-linked genes RbAp46,Rsk4,and Cldn2 in breast cancer[J].Mol Cancer Res, 2007,5(2 ) : 171-181.
  • 2Livak KJ,Schmittgen TD.Analysis of relative gene expression data using real-time quantitative PCR and the 2 (-Delta Delta C (T)) Method[J].Methods, 2001,25(4) :402-408.
  • 3Thakur A, Xu H, Wang Y, et al.The role of X-linked genes in breast cancer[J].Breast Cancer Res Treat,2005,93(2) : 135-143.
  • 4Dummler BA, Hauge C,Silber J,et al.Functional characterization of human RSK4,a new 90-kDa ribosomal S6 kinase,reveals constitu- tive activation in most cell types[J].J Biol Chem, 2005,280( 14): 13304-13314.
  • 5Thakur A, Sun Y, Bollig A, et al.Anti-invasive and antimetastatic ac- tivities of ribosomal protein S6 kinase 4 in breast cancer cells[J]. Clin Cancer Res, 2008,14(14) : 4427-4436.
  • 6Eisinger-Mathason TS,Andrade J, Lannigan DA.RSK in tumorigene- sis:connections to steroid signaling [ J ].Steroids, 2010,75 ( 3 ) : 191 - 202.
  • 7李永继,黄怡,阮细玲,廖柳凤,吴琼,黄文涛,徐恒.重组质粒BFP-cyclin D1的构建及表达对乳腺癌MCF-7细胞增殖和迁移能力的影响[J].中国癌症防治杂志,2012,4(2):174-178. 被引量:1
  • 8张晓丽,刘剑仑,杨华伟,韦薇,蒋奕,Dezhong Joshua Liao.抑癌基因RSK4的表达与乳腺癌细胞体外侵袭力的相关性研究[J].中国肿瘤临床,2011,38(6):308-311. 被引量:7
  • 9Chiu YL,Rana TM.RNAi in human cells:basic structural and fuc- tional features of small interfering RNA [ J ].Mol Cell, 2002,10 ( 3 ) : 549-561.
  • 10Stewart SA, Dykxhoom DM,Palliser D, et al.Lentivirus-delivered stable gene silencing by RNAi in primary cells [J].RNA,2003,9 (4):493-501.

二级参考文献29

  • 1任勇亚,杜丽坚,冯振卿,冷静.肾透明细胞癌VHL基因突变与CyclinD1过度表达的相关性[J].癌症,2006,25(2):175-178. 被引量:7
  • 2杨玲,李连弟,陈育德,D.M.Parkin.中国乳腺癌发病死亡趋势的估计与预测[J].中华肿瘤杂志,2006,28(6):438-440. 被引量:279
  • 3徐恒,朱晓宇,张海江,石磊,李莉,宋楠萌,桑建利.G1期细胞周期相关蛋白对POLD1基因启动子活性的调控[J].自然科学进展,2007,17(6):716-723. 被引量:4
  • 4Thakur A, Sun Y, Bollig A, et al. Anti-invasive and antimetastatic activities of ribosomal protein S6 kinase 4 in breast cancer cells[J]. Clin Cancer Res, 2008, 14(14): 4427-4436.
  • 5Jemal A, Siegel R, XuJ, et al. Cancer statistics, 2010[J]. CA Cancer J Clin, 2010, 60(5): 277-300.
  • 6Esteva FJ, Cheli CD, Fritsche H, et al. Clinical utility of serum HER2/neu in monitoring and prediction of progression-free survival in metastatic breast cancer patients treated with trastuzumab-based therapies[J]. Breast Cancer Res, 2005, 7(4): R436-R443.
  • 7Frodin M, Gammeltoft S. Role and regulation of 90 kDa ribosomal S6kinase (RSK) in signal transduction[J]. Mol Cell Endocrinol, 1999,151 (1-2): 65-77.
  • 8Clark DE, Erring'ton TM, SmithJA, et al. The serine/threonine proteinkinase, p90 ribosomal S6 kinase, is an important regulator of prostate cancer cell proliferation[J]. Cancer Res, 2005, 65(8): 3108-3116.
  • 9Dummler BA, Hauge C, Silber J, et al. Functional characterization of human RSK4, a new 90-kDa ribosomal S6 kinase, reveals consti- tutive activation inmost cell types[J]. J Biol Chem, 2005, 280(14): 13304-13314.
  • 10Thakur A, Xu H, Wang Y, et al. The role of X-linked genes in breast cancer[J]. Breast Cancer Res Treat, 2005, 93(2): 135-143.

共引文献6

同被引文献23

  • 1Thakur A,Sun Y,Bollig A,et al.Anti-invasive and An- timetastatic activities of ribosomal protein s6 kinase 4 in breast cancer cells [J].Clin Cancer Res,2008,14(14): 4427-4436.
  • 2Preusser M,Heinzl H,Gelpi E,et al. Ki-67 index in in-tracranialependymoma :a promising histopathological can- didate biomarker[J]. Histopathology, 2008,53(1) : 39-47.
  • 3Jirstrom K,Stendahl M,Ryden L,et al. Adverse effect of adjuvant tamoxifen in premenopausal breast cancer with cyclinD1 gene amplification [J]. Cancer Res,2005,65: 8009-8016.
  • 4Han S,Park K,Bae BN,et al. Prognostic implication of cyclinE expression and its relationshop with cyclinSl and p27 kepl expression on tissur microarrays of node nega- tive breast cancer[J]. J Surg Oncol, 2003,83(4) : 241-247.
  • 5Shadidi KR, Aarvak T, Henriksen JE, et al. The chemoki- nesCCL5 ,CCL2 and CXCL12 play significant roles in the migration of Thl cells into rheumatoid synovial tissue [J]. Scand J Immunol, 2003,57(2) : 192-198.
  • 6Kato M, Kitayama J, Kazama S,et al. Expression paRem of CXC chemokine receptor-d is correlated with 1 ymph node metastasis in human invasive ductal carcinoma [J]. Breast Cancer Res, 2003,5(5) : 144-150.
  • 7Park SW,Chung NG,Hur SY,et al. Mutational analysis of hypoxia-related genes HIFI alpha and CUL2 in common human cancers[J]. APMIS, 2009, Dee, 117(12) : 880-885.
  • 8Bos R,vander Groep P,Greijer AE,et al. Levels of hypox- ia inducible factor-1α independently predict prognosis in- patients with lymplmode negative breast carcinoma [J]. Cancer, 2003,97(3): 1573-1581.
  • 9Wang H,Nan L,Yu D,et aL Antisense anti-MDM2 oligonu- cleotides as a novel therapeutic approach to human breast cancer:in vitro and in vivo activities and mechanisms[J]. Clin Cancer Res, 2001,7(11) : 3613-3624.
  • 10吴琍,田亮.乳腺癌组织中EGFR、Ki-67、MMP-9的表达变化及临床意义[J].山东医药,2009,49(38):85-86. 被引量:4

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部